Aurora Cannabis Soars 25% on Reliva CBD Acquistion (ACB Stock Analysis)

Aurora Cannabis (ACB) is up big on an important CBD acquisition called Reliva. The company sells CBD oil products for edible, topical, and pet uses. This is an excellent opportunity for Aurora to enter the US CBD market and add to their bottom line. The stock is up to $15 and I think we could see $30 by the end of the year. It's amazing to see ACB change and grow in such a short time. Everything looks much better since Terry Booth stepped down as CEO in February. ► Get a Free Share of Stock (I got MSFT) on Robinhood: https://bit.ly/2VCZxqr ► Get a Free Stock on Webull when You Deposit $100: https://bit.ly/2WPP7UP ► My Stock Portfolio: https://www.investortrip.com/portfolio/ ► My Favorite Investing Tools & Resources: https://www.investortrip.com/resources/ ► Twitter:‌ ‌https://www.twitter.com/InvestorTrip� �� ► Instagram: https://www.instagram.com/investortrip/ ‌ ‌ Disclaimer:‌ ‌I‌ ‌am‌ ‌not‌ ‌a‌ ‌certified‌ ‌financial‌ ‌advisor.‌ ‌This‌ ‌video‌ ‌is‌ ‌for‌ ‌information‌ ‌purposes‌ ‌only.‌ ‌Please‌ ‌do‌ ‌your‌ ‌own‌ ‌research‌ ‌before‌ ‌buying‌ ‌any‌ ‌investment.‌ ‌I‌ ‌am‌ ‌not‌ ‌responsible‌ ‌for‌ ‌any‌ gains‌ ‌or‌ ‌losses‌ ‌in‌ ‌your‌ ‌portfolio.‌ ‌ ‌ Affiliate‌ ‌Disclosure:‌ ‌Some‌ ‌of‌ ‌the‌ ‌links‌ ‌in‌ ‌the‌ ‌description‌ ‌are‌ ‌affiliate‌ ‌links‌ ‌and‌ ‌I‌ ‌may‌ ‌receive‌ compensation‌ ‌at‌ ‌no‌ ‌additional‌ ‌cost‌ ‌you.‌ ‌

Category